World Journal of Dentistry

Register      Login

VOLUME 10 , ISSUE 2 ( March-April, 2019 ) > List of Articles


Potential Role of Dimers in Oncology

S Satish Kumar, Sreena N Sreedharan

Citation Information : Kumar SS, Sreedharan SN. Potential Role of Dimers in Oncology. World J Dent 2019; 10 (2):83-83.

DOI: 10.5005/jp-journals-10015-1608

License: CC BY-NC 4.0

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2019; The Author(s).


PDF Share
  1. Robinson DR, Wu YM, Lin SF. The protein tyrosine kinase family of the human genome. Oncogene 2000;19:5548.
  2. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103:211.
  3. Zwick E, Bange J, Ullrich A. Receptor tyrosine kinases as targets for anticancer drugs. Trends Mol Med 2002;8:17.
  4. Turkson J, Kim JS, Zhang S, et al. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Cancer Ther 2004;3:261.
  5. Siddiquee K, Zhang S, Guida WC, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. J Proc Natl Acad Sci 2007;104:7391.
  6. Zhou J, Giannakakou P. Targeting microtubules for cancer chemotherapy. Curr Med Chem Anti-Cancer Agents 2005;5:65.
  7. Kuppens IELM. Current state of the art of new tubulin inhibitors in the clinic. Curr Clin Pharmacol 2006;1:57-70.
  8. Hadden MK, Blagg BSJ. Dimeric Approaches to Anti-Cancer Chemotherapeutics. Anticancer Agents Med Chem 2008;8(7): 807-816.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.